499 related articles for article (PubMed ID: 16387366)
1. Syntheses of vanadyl and zinc(II) complexes of 1-hydroxy-4,5,6-substituted 2(1H)-pyrimidinones and their insulin-mimetic activities.
Yamaguchi M; Wakasugi K; Saito R; Adachi Y; Yoshikawa Y; Sakurai H; Katoh A
J Inorg Biochem; 2006 Feb; 100(2):260-9. PubMed ID: 16387366
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of insulin-mimetic activities of vanadyl and zinc(II) complexes from the viewpoint of heterocyclic bidentate ligands.
Katoh A; Matsumura Y; Yoshikawa Y; Yasui H; Sakurai H
J Inorg Biochem; 2009 Apr; 103(4):567-74. PubMed ID: 19162327
[TBL] [Abstract][Full Text] [Related]
3. Novel vanadyl complexes with quinoxaline N(1),N(4)-dioxide derivatives as potent in vitro insulin-mimetic compounds.
Noblía P; Vieites M; Torre MH; Costa-Filho AJ; Cerecetto H; González M; Lavaggi ML; Adachi Y; Sakurai H; Gambino D
J Inorg Biochem; 2006 Feb; 100(2):281-7. PubMed ID: 16386797
[TBL] [Abstract][Full Text] [Related]
4. Orally active and long-term acting insulin-mimetic vanadyl complex:bis(picolinato)oxovanadium (IV).
Sakurai H; Fujii K; Watanabe H; Tamura H
Biochem Biophys Res Commun; 1995 Sep; 214(3):1095-101. PubMed ID: 7575515
[TBL] [Abstract][Full Text] [Related]
5. A family of insulinomimetic zinc(II) complexes of amino ligands with Zn(Nn) (n=3 and 4) coordination modes.
Yoshikawa Y; Kondo M; Sakurai H; Kojima Y
J Inorg Biochem; 2005 Jul; 99(7):1497-503. PubMed ID: 15921760
[TBL] [Abstract][Full Text] [Related]
6. Development of new insulinomimetic zinc(II) picolinate complexes with a Zn(N2O2) coordination mode: structure characterization, in vitro, and in vivo studies.
Yoshikawa Y; Ueda E; Kawabe K; Miyake H; Takino T; Sakurai H; Kojima Y
J Biol Inorg Chem; 2002 Jan; 7(1-2):68-73. PubMed ID: 11862542
[TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential.
Thompson KH; Liboiron BD; Sun Y; Bellman KD; Setyawati IA; Patrick BO; Karunaratne V; Rawji G; Wheeler J; Sutton K; Bhanot S; Cassidy C; McNeill JH; Yuen VG; Orvig C
J Biol Inorg Chem; 2003 Jan; 8(1-2):66-74. PubMed ID: 12459900
[TBL] [Abstract][Full Text] [Related]
8. The pharmacology of the insulinomimetic effect of zinc complexes.
Sakurai H; Adachi Y
Biometals; 2005 Aug; 18(4):319-23. PubMed ID: 16158223
[TBL] [Abstract][Full Text] [Related]
9. Anti-diabetic effects of vanadium(III, IV, V)-chlorodipicolinate complexes in streptozotocin-induced diabetic rats.
Li M; Ding W; Smee JJ; Baruah B; Willsky GR; Crans DC
Biometals; 2009 Dec; 22(6):895-905. PubMed ID: 19404749
[TBL] [Abstract][Full Text] [Related]
10. A novel drug delivery system for type 1 diabetes: insulin-mimetic vanadyl-poly(gamma-glutamic acid) complex.
Karmaker S; Saha TK; Yoshikawa Y; Yasui H; Sakurai H
J Inorg Biochem; 2006 Sep; 100(9):1535-46. PubMed ID: 16824605
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and insulin-mimetic activities of metal complexes with 3-hydroxypyridine-2-carboxylic acid.
Nakai M; Sekiguchi F; Obata M; Ohtsuki C; Adachi Y; Sakurai H; Orvig C; Rehder D; Yano S
J Inorg Biochem; 2005 Jun; 99(6):1275-82. PubMed ID: 15917081
[TBL] [Abstract][Full Text] [Related]
12. Aqueous chemistry of the vanadium(III) (V(III)) and the V(III)-dipicolinate systems and a comparison of the effect of three oxidation states of vanadium compounds on diabetic hyperglycemia in rats.
Buglyó P; Crans DC; Nagy EM; Lindo RL; Yang L; Smee JJ; Jin W; Chi LH; Godzala Iii ME; Willsky GR
Inorg Chem; 2005 Jul; 44(15):5416-27. PubMed ID: 16022540
[TBL] [Abstract][Full Text] [Related]
13. Bis(allixinato)oxovanadium(IV) complex is a potent antidiabetic agent: studies on structure-activity relationship for a series of hydroxypyrone-vanadium complexes.
Adachi Y; Yoshida J; Kodera Y; Katoh A; Takada J; Sakurai H
J Med Chem; 2006 Jun; 49(11):3251-6. PubMed ID: 16722643
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the insulin-like properties of zinc(II) complexes of 3-hydroxy-4-pyridinones: identification of a compound with glucose lowering effect in STZ-induced type I diabetic animals.
Moniz T; Amorim MJ; Ferreira R; Nunes A; Silva A; Queirós C; Leite A; Gameiro P; Sarmento B; Remião F; Yoshikawa Y; Sakurai H; Rangel M
J Inorg Biochem; 2011 Dec; 105(12):1675-82. PubMed ID: 22088976
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization and antidiabetic properties of N(1)-2,4-dihydroxybenzylidene-N(4)-2-hydroxybenzylidene-S-methyl-thiosemicarbazidato-oxovanadium(IV).
Yanardag R; Demirci TB; Ulküseven B; Bolkent S; Tunali S; Bolkent S
Eur J Med Chem; 2009 Feb; 44(2):818-26. PubMed ID: 18621448
[TBL] [Abstract][Full Text] [Related]
16. A [meso-tetrakis(4-sulfonatophenyl)porphyrinato]zinc(ii) complex as an oral therapeutic for the treatment of type 2 diabetic KKA(y) mice.
Saha TK; Yoshikawa Y; Sakurai H
ChemMedChem; 2007 Feb; 2(2):218-25. PubMed ID: 17245806
[TBL] [Abstract][Full Text] [Related]
17. Hypoglycemic effect of macrocyclic binuclear oxovanadium (IV) complex on streptozotocin-induced diabetic rats.
Ramachandran B; Sekar DS; Kandaswamy M; Narayanan V; Subramanian S
Exp Diabesity Res; 2004; 5(2):137-42. PubMed ID: 15203884
[TBL] [Abstract][Full Text] [Related]
18. Comparison of anti-hyperglycemic effect amongst vanadium, molybdenum and other metal maltol complexes.
Thompson KH; Chiles J; Yuen VG; Tse J; McNeill JH; Orvig C
J Inorg Biochem; 2004 May; 98(5):683-90. PubMed ID: 15134913
[TBL] [Abstract][Full Text] [Related]
19. A new insulin-mimetic bis(allixinato)zinc(II) complex: structure-activity relationship of zinc(II) complexes.
Adachi Y; Yoshida J; Kodera Y; Kato A; Yoshikawa Y; Kojima Y; Sakurai H
J Biol Inorg Chem; 2004 Oct; 9(7):885-93. PubMed ID: 15378407
[TBL] [Abstract][Full Text] [Related]
20. A new concept: the use of vanadium complexes in the treatment of diabetes mellitus.
Sakurai H
Chem Rec; 2002; 2(4):237-48. PubMed ID: 12203906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]